- Home
- MATH vs VRCA Comparison
MATH vs VRCA Comparison
Compare MATH & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- VRCA
- Stock Information
- Founded
- MATH 2015
- VRCA 2013
- Country
- MATH Hong Kong
- VRCA United States
- Employees
- MATH N/A
- VRCA N/A
- Industry
- MATH Finance/Investors Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- VRCA Health Care
- Exchange
- MATH Nasdaq
- VRCA Nasdaq
- Market Cap
- MATH 60.8M
- VRCA 65.4M
- IPO Year
- MATH N/A
- VRCA 2018
- Fundamental
- Price
- MATH $3.41
- VRCA $0.80
- Analyst Decision
- MATH
- VRCA Hold
- Analyst Count
- MATH 0
- VRCA 5
- Target Price
- MATH N/A
- VRCA $6.00
- AVG Volume (30 Days)
- MATH 168.3K
- VRCA 763.3K
- Earning Date
- MATH 08-26-2025
- VRCA 08-13-2025
- Dividend Yield
- MATH N/A
- VRCA N/A
- EPS Growth
- MATH N/A
- VRCA N/A
- EPS
- MATH 0.17
- VRCA N/A
- Revenue
- MATH $31,399,049.00
- VRCA $7,179,000.00
- Revenue This Year
- MATH N/A
- VRCA $171.87
- Revenue Next Year
- MATH N/A
- VRCA $71.38
- P/E Ratio
- MATH $22.36
- VRCA N/A
- Revenue Growth
- MATH 291.58
- VRCA N/A
- 52 Week Low
- MATH $0.80
- VRCA $0.38
- 52 Week High
- MATH $4.17
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- MATH 50.38
- VRCA 61.35
- Support Level
- MATH $3.40
- VRCA $0.72
- Resistance Level
- MATH $3.85
- VRCA $0.67
- Average True Range (ATR)
- MATH 0.31
- VRCA 0.10
- MACD
- MATH -0.01
- VRCA 0.02
- Stochastic Oscillator
- MATH 48.62
- VRCA 64.43
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.